装备制造企业动态能力评价及其实证研究

阐释了装备制造企业动态能力的概念内涵与构成要素,设计出由市场感知、组织学习、资源获取、重构与转变、协调与控制5个动态能力一级指标和20个二级指标组成的评价指标体系,采用AHP法确定指标权重。针对指标度量的模糊性与不确定性,建立了证据推理的数据融合方法,并对江淮汽车集团动态能力进行了实证分析。     

Optimal insurance in the presence of reinsurance

This paper studies an optimal insurance and reinsurance design problem among three agents: policyholder, insurer, and reinsurer. We assume that the preferences of the parties are given by distortion risk measures, which are equivalent to dual utilities. By maximizing the dual utility of the insurer and jointly solving the optimal insurance and reinsurance contracts, it is found that a layering insurance is optimal, with every layer being borne by one of the three agents. We also show that reinsurance encourages more insurance, and is welfare improving for the economy. Furthermore, it is optimal for the insurer to charge the maximum acceptable insurance premium to the policyholder. This paper also considers three other variants of the optimal insurance/reinsurance models. The first two variants impose a limit on the reinsurance premium so as to prevent insurer to reinsure all its risk. An optimal solution is still layering insurance, though the insurer will have to retain higher risk. Finally, we study the effect of competition by permitting the policyholder to insure its risk with an insurer, a reinsurer, or both. The competition from the reinsurer dampens the price at which an insurer could charge to the policyholder, although the optimal indemnities remain the same as the baseline model. The reinsurer will however not trade with the policyholder in this optimal solution.     

无形资产对公司资本结构的影响研究

针对无形资产是否可以起到有效的债务支持替代作用进而影响企业资本结构这一当前少有文献实证探讨的问题,结合我国实际融资环境实证分析无形资产对企业负债水平及资本结构的影响程度和机制.研究发现,企业无形资产投入与负债支持能力及资产负债率显著正相关,实际上发挥出了对有形资产债务支持的替代作用.     

银行业市场竞争对企业技术创新的影响研究

银行贷款是企业创新的重要融资来源,银行业市场的变化影响着企业技术创新的融资环境.基于2008-2014年沪深A股上市公司的实证检验发现:银行市场竞争性的提高有利于缓解企业的融资约束,促进企业技术创新.企业规模对中小企业的技术创新有正向的影响,对大型企业存在负的效应.银行业市场竞争对企业技术创新的影响也因企业规模不同而不同,中小企业受到的融资约束明显,银行业竞争度的提高更有利于促进中小企业的技术创新.     

Efficiency in Turkish banking: post-restructuring evidence

Turkish banking sector went through a significant restructuring process in the aftermath of the country's financial crisis of 2000–2001. In this paper, we analyze the evolution of banking performance using a novel approach due to Ray [(2007). “Shadow Profit Maximization and a Measure of Overall Inefficiency.” Journal of Productivity Analysis 27, 231–236]. We derive ‘shadow unrealized profit scores’ as well as ‘shadow input–output prices’ for each year and bank in the sector from 2002 to 2011. We argue these scores operationalize the Hicksian concept of ‘monopolistic quiet life’. We provide some evidence the sector came closer to the ‘zero profit condition’ as well as displaying a closer approximation to the ‘law of one price’ over time. We show the variability of these ‘shadow prices’ essentially coincides with that of corresponding actual prices. We utilize shadow price information to show that business models and competitive choices of banks differ across ownership types with foreign banks competing on the broadest front compared to state-owned and privately owned Turkish banks.     

Examining technological competition between BMW and Hyundai in the Korean car market

The Korean car market has increased in size. BMW and Hyundai are the top-ranked imported and domestic vehicle brands in Korea, respectively. Thus, it is important to understand these companies and the Korean car market, because technology is most significant in the vehicle industry. In this paper, we compare BMW with Hyundai from the technological perspective. Our research is focused on an analysis of the technological competition between BMW and Hyundai based on their developed technologies. We use all BMW and Hyundai patents from worldwide patent databases to analyse the two companies’ technologies. In addition, we apply statistical methods and machine learning algorithms to the patent analysis. In our conclusion, we show the technological differences and competition between BMW and Hyundai, and find their relative strengths and weaknesses.     

Innovation ecosystems and the pace of substitution: Re‐examining technology S‐curves

Why do some new technologies emerge and quickly supplant incumbent technologies while others take years or decades to take off? We explore this question by presenting a framework that considers both the focal competing technologies as well as the ecosystems in which they are embedded. Within our framework, each episode of technology transition is characterized by the ecosystem emergence challenge that confronts the new technology and the ecosystem extension opportunity that is available to the old technology. We identify four qualitatively distinct regimes with clear predictions for the pace of substitution. Evidence from 10 episodes of technology transitions in the semiconductor lithography equipment industry from 1972 to 2009 offers strong support for our framework. We discuss the implication of our approach for firm strategy. Copyright © 2015 John Wiley & Sons, Ltd.     

Crowding,satiation, and saturation: The days of television series' lives

The performance of firms depends not just on the structure of the industries in which they compete but also on their relative positioning within those industries, in terms of operating within particular niches. We propose that demand for these niches depends endogenously on the historical ecology of the products offered: Niches become saturated—reduced in their ability to support products—as a large number of previous offerings allows the audience to satisfy its desire for products of a particular type. Analyzing the survival rates of television series aired in the United States from 1946 to 2003, we found that the survival rates of future entrants fell with the extensiveness of recent offerings in the niche, and that the negative association between crowding and survival also weakened with this saturation. Copyright © 2014 John Wiley & Sons, Ltd.     

Corporate governance structure and product market competition

This article assesses the effects of the competitive structure of a product market on a firm’s corporate governance structure. Our model demonstrates that shareholders strategically determine the corporate governance structure, including the manager’s stock ownership and his controlling power over the firm, in order to maximize their utility in the product market competition. We find that the manager’s stock ownership is lower and his controlling power over the firm is higher when the firm’s product is more profitable or when competition within the product market is more severe. The inefficiency of the wealth transfer from shareholders to the manager also affects the corporate governance structure.     

Updated trends in US brand-name and generic drug competition

Objective: To provide updated evidence on US trends in: market exclusivity periods (MEPs, time between brand-name drug launch and first generic competitors) for new molecular entities (NMEs); likelihood, timing and number of Hatch-Waxman Act Paragraph IV patent challenges; and generic drug penetration.

Methods: This study used IMS Health National Sales Perspectives^TM US data to calculate MEPs for the 288 NMEs experiencing initial generic entry between January 1995 and December 2014, the number of generic competitors for 12 months afterward (by level of annual sales prior to generic entry), and generic penetration rates. The likelihood, timing and number of Paragraph IV challengers were calculated using data from Abbreviated New Drug Approval (ANDA) letters, the FDA website, public information searches, and ParagraphFour.com.

Results: For drugs experiencing initial generic entry in 2013–2014, the MEP was 12.5 years for drugs with sales greater than $250 million (in 2008 dollars) in the year prior to generic entry ($250 million?+?NMEs), 13.6 years overall. After generic entry, brands rapidly lost sales, with their average unit share being 7% at 1 year for $250 million?+?NMEs, 12% overall. Ninety-four percent of $250 million?+?NMEs experiencing initial generic entry in 2013–2014 had faced at least one Paragraph IV challenge, an average of 5.2 years after brand launch (76% and 5.9 years for all NMEs). NMEs faced an average of 5.1 and 6.2 Paragraph IV challenges per NME, for all and $250 million?+?NMEs, respectively.

Limitations: Analyses, including Paragraph IV calculations, were restricted to NMEs where generic entry had occurred.

Conclusion: The average 2013–2014 MEP of 12.5 years for $250 million?+?NMEs, 13.6 overall remains consistent with prior research. MEPs are lower, and Paragraph IV challenges are more frequent and occur earlier for $250 million?+?drugs. Generic share erosion is also greater, and continues to intensify for both NME types.